03.08.2007 20:31:00

Abbott Chief Operating Officer Richard A. Gonzalez to Retire

ABBOTT PARK, Ill., Aug. 3 /PRNewswire-FirstCall/ -- Richard A. Gonzalez, president and chief operating officer, and a member of Abbott's board of directors, plans to retire after a distinguished 30-year career with the company.

"Rick is a consummate leader and has had a distinguished career at Abbott, including his work to help conceive and execute Abbott's successful medical products strategy," said Miles D. White, chairman and chief executive officer, Abbott. "He is a close friend and colleague with whom I've worked virtually my whole career at Abbott. I thank him for his many great contributions to our company and wish him the very best in his retirement."

Gonzalez will remain with Abbott until Sept. 30, 2007. Upon his retirement, the heads of Abbott's four operating businesses -- medical devices, pharmaceuticals, nutritionals and diagnostics -- will report directly to Mr. White.

About Abbott

Abbott is a global, broad-based health care company devoted to the discovery, development, manufacture and marketing of pharmaceuticals and medical products, including nutritionals, devices and diagnostics. The company employs 65,000 people and markets its products in more than 130 countries.

Abbott's news releases and other information are available on the company's Web site at http://www.abbott.com/.

JETZT DEVISEN-CFDS MIT BIS ZU HEBEL 30 HANDELN
Handeln Sie Devisen-CFDs mit kleinen Spreads. Mit nur 100 € können Sie mit der Wirkung von 3.000 Euro Kapital handeln.
82% der Kleinanlegerkonten verlieren Geld beim CFD-Handel mit diesem Anbieter. Sie sollten überlegen, ob Sie es sich leisten können, das hohe Risiko einzugehen, Ihr Geld zu verlieren.

Analysen zu Abbott Laboratoriesmehr Analysen

Eintrag hinzufügen
Hinweis: Sie möchten dieses Wertpapier günstig handeln? Sparen Sie sich unnötige Gebühren! Bei finanzen.net Brokerage handeln Sie Ihre Wertpapiere für nur 5 Euro Orderprovision* pro Trade? Hier informieren!
Es ist ein Fehler aufgetreten!

Aktien in diesem Artikel

Abbott Laboratories 112,54 0,21% Abbott Laboratories

Indizes in diesem Artikel

NASDAQ Comp. 19 218,17 0,83%
S&P 500 6 032,38 0,56%
NYSE US 100 17 376,20 -0,02%